GRCE Grace Tx: Price Chart

Graphic logo of gracetx.com (GRCE)

Biotechnologies for the therapy of nervous system disorders are not subject to market cycles or seasonality, which is confirmed by the market trend of Grace Therapeutics, Inc. (GRCE) share prices, where the metric reaches 1.82. Grace Therapeutics, Inc. (GRCE), in collaboration with scientific funds, is seeking ways to mitigate pain and childhood pathologies. The company is betting on the creation of unique injections for rare diseases, aiming to secure a monopoly position through orphan status.

GRCE - Grace Therapeutics, Inc. Stock Quotes over the range 10/29/2024 - 11/16/2026

Grace Therapeutics, Inc. (GRCE) - metric breakdowns and financial figures

Analysis of all company metrics:Grace Therapeutics Inc GRCE
Signature product of Grace Tx

The price consolidates market expectations regarding the capitalization of Grace Therapeutics, Inc. (GRCE), transforming fundamental performance metrics into a single quotation equivalent. By analyzing the price action of the securities, an investor assesses how successfully Grace Therapeutics, Inc. (GRCE) converts the intellectual capital of rare biochemists and the absence of bureaucracy into asset value, which confirms the resilience of the business model through market recognition of its mission.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel